ABSTRACT
Tuberculosis (TB) poses a significant global public health challenge, particularly in developing countries. Over the years, scientific research has played a pivotal role in addressing this disease. In this study, we aimed to analyze and outline the trends in scientific output on TB and identify research priorities in Latin America (LA) from 1990 to 2021. Scientific production was analyzed, and the number of publications, financing sources, and journal characteristics were evaluated. Collaboration networks and keywords were visualized using mapping analysis with VOSviewer software. Research themes were prioritized by country based on co-occurrence frequency. In total, 4399 documents were identified, a significant trend was evident in the number of publications per year (R2 = 0.981), and research substantially contributed to the reduction of TB-related mortality (R2 = -0.876). Most publications were original articles (83.8 %). The International Journal of Tuberculosis and Lung Disease had the highest publication and citation rates per document. International collaboration was predominantly with the United States, France, and Canada. Brazil, Argentina, and Mexico had the highest number of publications and external collaborations. In LA, interest in researching studies related to treatment and diagnosis (32.5 %) was notably high, followed by epidemiology and screening (26.9 %). Among the 20 countries in LA, research priorities varied, with the highest emphasis on HIV/AIDS (14/20), epidemiology (9/20), anti-TB agents (6/20), and mortality (5/20). TB resistance was only considered a research priority in Brazil, Peru, and Haiti. Therefore, LA experienced significant growth in its scientific output, playing a crucial role in TB control. Strategic adaptation to the region's specific challenges was observed, particularly in HIV/AIDS coinfection, epidemiological studies, and drug resistance. This progress was achieved by outstanding international scientific collaboration. This holistic approach emphasizes the importance of research in the fight against TB in LA.
ABSTRACT
BACKGROUND: A recent Lancet commission called for more research on palliative care in low- and middle-income (LMIC) countries such as Colombia. A research priority setting approach has been recommended by The Global Forum for Health Research to address the huge gap in research output between LMIC and high-income countries, with influential health service bodies recommending the active involvement of non-research expert stakeholders in establishing research priorities to address service user needs. METHOD: Priority setting partnership (PSP) following the four stages of the James Lind Alliance methodology; establishing the partnership, identifying evidence uncertainties, refining questions and uncertainties, and prioritization. Data from MS forms were analysed using descriptive statistics. RESULTS: A total of 33 stakeholders attended an online PSP workshop and completed the Mentimeter exercise in Microsoft Teams. A total of 48 attended the subsequent in person prioritisation exercise in urban Bogota (n = 22) and rural Popayan (n = 25). The stakeholders were a diverse group of health professionals (physicians, medical students, nurses, dentists, physiotherapists, nutritionist, occupational and speech therapists), financial and administrative staff and patients with life-limiting illness and caregivers. Top research priorities included patient and caregiver needs, service provider education and training, and better integration of palliative care with cancer and non-cancer services. The key challenges included a lack of interest in palliative care research, along with funding, time and resource constraints. Key solutions included collaboration across disciplines and settings, highlighting benefits of palliative research to help secure adequate resources, and multicentre, mixed method research, with patient involvement from the research development stage. CONCLUSION: The findings of this PSP should be disseminated among palliative care associations worldwide to inform international multicentre studies, and among governmental and nongovernmental organisations that promote research in Colombia. A focus on patient and family caregiver palliative care needs in Colombia should be prioritised.
Subject(s)
Palliative Care , Humans , Palliative Care/methods , Palliative Care/standards , Palliative Care/trends , Colombia , Research/trends , Health Priorities/trendsABSTRACT
Evidence-based and person-centred care requires the measurement of treatment outcomes that matter to youth and mental health practitioners. Priorities, however, may vary not just between but also within stakeholder groups. This study used Q-methodology to explore differences in outcome priorities among mental health practitioners from two countries in relation to youth depression. Practitioners from the United Kingdom (UK) (n = 27) and Chile (n = 15) sorted 35 outcome descriptions by importance and completed brief semi-structured interviews about their sorting rationale. By-person principal component analysis (PCA) served to identify distinct priority profiles within each country sample; second-order PCA examined whether these profiles could be further reduced into cross-cultural "super profiles". We identified three UK outcome priority profiles (Reduced symptoms and enhanced well-being; improved individual coping and self-management; improved family coping and support), and two Chilean profiles (Strengthened identity and enhanced insight; symptom reduction and self-management). These could be further reduced into two cross-cultural super profiles: one prioritized outcomes related to reduced depressive symptoms and enhanced well-being; the other prioritized outcomes related to improved resilience resources within youth and families. A practitioner focus on symptom reduction aligns with a long-standing focus on symptomatic change in youth depression treatment studies, and with recent measurement recommendations. Less data and guidance are available to those practitioners who prioritize resilience outcomes. To raise the chances that such practitioners will engage in evidence-based practice and measurement-based care, measurement guidance for a broader set of outcomes may be needed.
Subject(s)
Depression , Mental Health , Humans , Adolescent , Chile , United Kingdom , Treatment OutcomeABSTRACT
BACKGROUND: Telehealth has emerged as an alternative model for treatment delivery and has become an important component of health service delivery. However, there is inconsistency in the use of terminologies and a lack of research priorities in telehealth in musculoskeletal pain. The purpose of this international, multidisciplinary expert panel assembled in a modified three-round e-Delphi survey is to achieve a consensus on research priorities and for the standard terminology for musculoskeletal pain telehealth practice. METHODS: In this international modified e-Delphi survey, we invited an expert panel consisting of researchers, clinicians, consumer representatives, industry partners, healthcare managers, and policymakers to participate in a three-round e-Delphi. Expert panels were identified through the Expertscape website, PubMed database, social media, and a snowball approach. In Round 1, potential research priorities and terminologies were presented to panel members. Panel members rated the agreement of each research priority on a 5-point Likert scale and an 11-point numerical scale, and each terminology on a 5-point Likert scale for the "telehealth in musculoskeletal pain " field over rounds. At least 80% of the panel members were required to agree to be deemed a consensus. We analyzed the data descriptively and assessed the stability of the results using the Wilcoxon matched-pairs signed rank test. RESULTS: We performed an international e-Delphi survey from February to August 2022. Of 694 invited people, 160 panel members participated in the first round, 133 in the second round (83% retention), and 134 in the third round (84% retention). Most of the panel members were researchers 76 (47%), clinicians 57 (36%), and consumer representatives 9 (6%) of both genders especially from Brazil 31 (19%), India 22 (14%), and Australia 19 (12%) in the first round. The panel identified fourteen telehealth research priorities spanned topics including the development of strategies using information and communication technology, telehealth implementation services, the effectiveness and cost-effectiveness of telehealth interventions, equity of telehealth interventions, qualitative research and eHealth literacy in musculoskeletal pain conditions from an initial list of 20 research priorities. The consensus was reached for "digital health" and "telehealth" as standard terminologies from an initial list of 37 terminologies. CONCLUSION: An international, multidisciplinary expert consensus recommends that future research should consider the 14 research priorities for telehealth musculoskeletal pain reached. Additionally, the terms digital health and telehealth as the most appropriate terminologies to be used in musculoskeletal telehealth research. REGISTER: Open Science Framework ( https://osf.io/tqmz2/ ).
Subject(s)
Biomedical Research , Musculoskeletal Pain , Telemedicine , Humans , Male , Female , Consensus , Delphi Technique , Musculoskeletal Pain/diagnosis , Musculoskeletal Pain/therapyABSTRACT
Social determinants of health contribute to health disparities and inequities. We conducted a community forum on the topic of isolation with the objectives of (1) identifying and prioritizing key health-related issues needing attention in isolated communities in Puerto Rico; (2) developing strategies in terms of Policies, Programs, and Practices to address the community priorities we identified. We used the triangulation method for qualitative data, integrating the Colorado State University's Tri-ethnic Center Model and the Delphi Technique for a better understanding of community health needs and priorities. The five community health-related priorities identified in the community forum were: (1) access to health services (physical and mental); (2) older adults; (3) access to basic services; (4) preparedness for future disasters/emergencies; and (5) COVID-19 and access to vaccination. The Alliance Leaders and Advisory Boards understand that we will work with the priorities of preparedness for future natural disasters/emergencies and COVID-19 and access to vaccination. Fifteen strategies were developed for these priorities and were grouped into five areas that require more attention in order to reduce health disparities. Isolated communities in Puerto Rico present an intersectionality of factors that affect a wide range of health-related risks and outcomes.
Subject(s)
COVID-19 , Disasters , Humans , Aged , Puerto Rico/epidemiology , Emergencies , COVID-19/epidemiology , COVID-19/prevention & control , Public HealthABSTRACT
El Instituto Nacional de Salud, ha llevado a cabo por primera vez el proceso de identificación de Prioridades Nacionales de Investigación en Salud Bucal a cargo de la Subdirección de Investigación y Laboratorios de Enfermedades No Transmisibles del Centro Nacional de Salud Pública con la asesoría técnica de la Dirección de Investigación e Innovación en Salud y en coordinación con la Dirección Ejecutiva de Salud Bucal de la Dirección General de Intervenciones Estratégicas en Salud Pública del Ministerio de Salud mediante metodología participativa de tres actores claves: investigadores/especialistas, expertos y decisores. El objetivo de este artículo es describir el proceso seguido para la identificación de estas prioridades, el cual comprendió cinco fases: i) identificación de objetivos estratégicos del MINSA, ii) identificación de necesidades de investigación en salud bucal, iii) revisión por expertos y valoración de las necesidades según criterios, iv) priorización (valoración de la lista de prioridades según calificación) y v) presentación de las prioridades. Como resultado se obtuvieron las 12 prioridades que posteriormente fueron aprobadas por Resolución Ministerial N.° 262-2022/MINSA, con un periodo de vigencia 2022-2026. Además, se brindaron recomendaciones para futuros procesos.
The National Institute of Health has, for the first time, identified National Priorities for Oral Health Research, this process was carried out by the Subdirectorate of Research and Laboratories of Noncommunicable Diseases of the National Center for Public Health with the technical advice of the Directorate of Research and Innovation in Health and in coordination with the Executive Directorate of Oral Health of the General Directorate of Strategic Interventions in Public Health of the Ministry of Health, using a participatory methodology with three key actors: researchers/specialists, experts and decision-makers. This article aims to describe the process used to identify these priorities, which consisted of five phases: i) identification of the strategic objectives of the Ministry of Health, ii) identification of needs in oral health research, iii) review by experts and assessment of needs according to criteria and v) presentation of the priorities. As a result, 12 priorities were obtained, which were subsequently approved by Ministerial Resolution No. 262-2022/MINSA, for a period of 2022-2026. In addition, we provide recommendations for future processes.
ABSTRACT
Introducción. La giardiasis es ocasionada por el protozoario intestinal Giardia lamblia, su transmisión tiene variabilidad geográfica y a pesar de ser muy frecuente, no existe una herramienta de estratificación de riesgo para priorizar las intervenciones. Objetivo. Estimar la prevalencia de G. lamblia en preescolares y escolares peruanos por ecorregiones entre 1990 a 2018. Métodos. A partir de un metaanálisis previo, se realizó un subanálisis por ecorregiones de la prevalencia de G. lamblia en 26 estudios en preescolares y escolares peruanos entre 1990 a 2018. Se extrajeron los datos por distrito y utilizando Google Earth fueron clasificados en ecorregiones. La heterogeneidad fue analizada mediante la prueba de Q de Cochrane y el sesgo de publicación mediante el método de Egger con StatsDirect versión 3.2.7. Se utilizó el método de riesgo absoluto para estratificar la prevalencia a nivel de distrito y se definió 4 estratos en base a los percentiles o arbitrariamente. Resultados. Se identificaron 43 datos de prevalencia a nivel de distrito que incluyeron 7606 participantes. Las prevalencias combinadas más altas por el método de efectos aleatorios de G. lamblia fueron de 47,0% intervalo de confianza (IC) 95%: 40,0 -54,0) en el desierto del Pacífico; 27,9% (IC95%: 22,8 - 33,2) en selva baja y 26,9% (IC95%: 22,5 -31,5) en la Puna. Conclusiones. De cada 100 preescolares y escolares que viven en las ecorregiones del desierto del Pacífico, selva baja y Puna, 47, 28 y 27 menores de edad, respectivamente, están infectados con G. lamblia. Asimismo, se propone 4 estratos de riesgo en función de la prevalencia: esporádico (0 a <1%), hipoendémico (1 a <25%), mesoendémico (≥ 25 a <50%) e hiperendémico (≥50%).
Introduction. Giardiasis is caused by an intestinal protozoan, Giardia lamblia. Despite its high prevalence and geographical transmission variability, there is no risk stratification tool available to prioritize interventions. Objective. To estimate the prevalence of G. lamblia in Peruvian preschoolers and schoolchildren by ecoregion from 1990 to 2018. Methods. Based on a previous meta-analysis, we conducted a G. lamblia prevalence sub-analysis by ecoregions from data of 26 studies in Peruvian preschoolers and school-aged children between 1990 and 2018. The data was extracted by district, a classification by ecoregions was made through Google Earth. Heterogeneity was analyzed using Cochrane Q test and publication bias applying the Egger method with StatsDirect version 3.2.7. The absolute risk method was performed to stratify the prevalence at district level, and 4 strata were defined based on percentiles or arbitrarily. Results. Forty-three district-level prevalence data was estimated, including 7,606 participants. The highest pooled prevalences by the random effects method of G. lamblia were 47.0% (95% CI: 40.0-54.0) in the Pacific desert, 27.9% (95% CI: 22.8-33.2) in the lowland forest and 26.9% (95% CI 22.5-31.5) in the Puna. Conclusions. Of every 100 preschoolers and school-aged children living in the Pacific desert, lowland forest, and in the Puna ecoregions, 47, 28, and 27 minors are infected with G. lamblia, respectively. Likewise, 4 risk strata are proposed based on prevalence: sporadic (0 to <1%), hypoendemic (1 to <25%), mesoendemic (≥25 to <50%) and hyperendemic (≥50%).
ABSTRACT
Health systems have committed their path to universal health coverage using health planning to accomplish their goals of efficiency, equity and sustainability. Chile, a high-income country with a public-private mix health system, has made significant progress through several successive health policies implemented in the last 20 years which have been consistent with this approach. However, in the last 5 years, the national congress has produced several disease-specific laws, which have been mainly promoted by the civil society. These laws indicate the actions the health authority must perform to tackle the needs of the affected population, which ultimately determine the priorities of the health system. We argue that this legal pattern has become an alternative path to priority-setting, as opposed to health planning. We claim this "legal path" is a mechanism used by civil society in a context where the health authority fails to implement a robust and legitimate prioritization process. Although these laws have brought benefits to patients suffering the corresponding conditions, we highlight this approach does not guarantee improvements in equity, efficiency and health system performance. Instead, we advocate for taking back the control of the priority-setting based on health planning, through a new institutionalization of health technology assessment and quality of care.
Subject(s)
Health Planning , Health Policy , United States , Humans , Chile , Income , Technology Assessment, BiomedicalABSTRACT
O objetivo deste artigo é desenvolver um índice de priorização para aceleração do cumprimento das metas nacionais de saúde propostas pela Agenda 2030. Trata-se de estudo ecológico que abordou as Regiões de Saúde do Brasil. O índice incorporou 25 indicadores com proximidade analítica aos indicadores oficiais da Agenda 2030, para os quais existem dados de fontes públicas no nível municipal para o período de 2015 a 2019. O índice apresentou-se como potente método para apoiar a decisão da gestão em saúde. Os resultados permitiram identificar que a Região Norte do país apresenta os territórios mais vulneráveis e, portanto, prioritários para a alocação de recursos. Além disso, a análise dos subíndices permitiu destacar os gargalos locais de saúde, reforçando a necessidade de os municípios de cada região estabelecerem suas próprias prioridades na decisão de alocação dos recursos da saúde. Ao indicar as Regiões de Saúde e os temas prioritários para maiores investimentos, esta investigação aponta caminhos que podem apoiar a implementação da Agenda 2030 do nível local ao nacional, além de fornecer elementos por meio dos quais os formuladores de políticas podem minimizar os efeitos das iniquidades sociais sobre a saúde, priorizando os territórios com piores índices.
El objetivo fue desarrollar un índice de priorización para acelerar el cumplimiento de las metas nacionales de salud propuestas por la Agenda 2030. Se trata de un estudio ecológico que abordó las Regiones de Salud de Brasil. El índice incorporó 25 indicadores con proximidad analítica a los indicadores oficiales de la Agenda 2030 para los cuales existen datos de fuentes públicas a nivel municipal para el período 2015-2019. El índice se presentó como potente método para apoyar la decisión de la gestión en salud. Los resultados permitieron identificar que la Región Norte del país cuenta con los territorios más vulnerables y, por tanto, áreas prioritarias para la asignación de recursos. Además, el análisis de los subíndices permitió resaltar cuellos de botella locales en salud, reforzando la necesidad de que los municipios de cada región establezcan sus propias prioridades en la decisión de asignación de recursos en salud. Al indicar las Regiones de Salud y los temas prioritarios para mayores inversiones, esta investigación apunta caminos que pueden apoyar la implementación de la Agenda 2030 desde el nivel local al nacional, además de proporcionar elementos a través de los cuales los formuladores de políticas pueden minimizar los efectos de las inequidades sociales sobre la salud, priorizando los territorios con peores índices.
This study aimed to develop a prioritization index to speed up the achievement of national health targets proposed in the 2030 Agenda. This is an ecological study that addressed the Health Regions in Brazil. The index incorporated 25 indicators with analytical proximity to the official indicators of the 2030 Agenda whose data are available from public municipal sources for the period of 2015-2019. According to our study, the index was a powerful method to support health management decisions. The results showed the most vulnerable territories are located in the North Region of the country, and therefore, these are priority areas for resource allocation. The analysis of subindices highlighted local health bottlenecks, reinforcing the need for municipalities in each region to set their own priorities while making decisions for health resource allocation. By indicating Health Regions and priority themes for more investments, this investigation shows paths to support the implementation of the 2030 Agenda, from the local to the national level, in addition to providing elements that can be used by policy makers to minimize the effects of social inequalities on health, prioritizing territories with worse indices.
ABSTRACT
ABSTRACT Working with PAHO/WHO to prioritize childhood cancer in the context of systems strengthening is central to St. Jude Children's Research Hospital (SJCRH)'s role as WHO Collaborating Centre for Childhood Cancer. This manuscript focuses on how SJCRH and PAHO/WHO have partnered to apply C5 (Country Collaboration for Childhood Cancer Control) to define and implement priority actions regionally, strengthening Ministry programs for childhood cancer, while implementing the Global Initiative for Childhood Cancer since 2018. Using C5, a tool developed by SJCRH, PAHO/WHO and SJCRH co-hosted regional/national workshops engaging authorities, clinicians and other stakeholders across 10 countries to map health systems needs and prioritize strategic activities (spanning Central America, Dominican Republic, Haiti, Brazil and Uruguay). SJCRH provided English/Spanish/Portuguese C5 versions/templates for analysis/prioritization exercises, and worked with PAHO/WHO and country teams to implement C5, analyze findings, and develop outputs. In an eight-country regional workshop, countries defined priorities within national/regional initiatives and ranked their value and political will, incorporating country-specific surveys and stakeholder dialogues. Each country prioritized one strategic activity for 2022-2023, exchanged insights via storytelling, and disseminated and applied results to inform country-specific and regional action plans. National workshops analyses have been incorporated into cancer control planning activities and collaborative work regionally. Implementation success factors include engaging actors beyond the clinic, enabling flexibility, and focusing on co-design with stakeholders. Joint implementation of C5 catalyzed prioritization and accelerated strategic activities to improve policies, capacity, and quality of care for children in the Americas, supporting Ministries to integrate childhood cancer interventions as part of systems strengthening.
RESUMEN La colaboración con la OPS/OMS para priorizar el cáncer infantil en el contexto del fortalecimiento de los sistemas es fundamental para la labor del St. Jude Children's Research Hospital (SJCRH) como centro colaborador de la OMS contra el cáncer infantil. Este artículo se centra en la alianza entre el SJCRH y la OPS/OMS en la aplicación de la herramienta C5 (colaboración nacional para el control del cáncer infantil) para definir y ejecutar medidas prioritarias a nivel regional, fortalecer los programas contra el cáncer infantil del ministerio y poner en marcha la Iniciativa Mundial contra el Cáncer Infantil desde el 2018. Con C5, una herramienta elaborada por el SJCRH, la OPS/OMS y este hospital organizaron conjuntamente talleres regionales y nacionales con autoridades, personal médico y otras partes interesadas en diez países para determinar cuáles son las necesidades de los sistemas de salud y priorizar las actividades estratégicas (en América Central, República Dominicana, Haití, Brasil y Uruguay). El SJCRH proporcionó versiones y plantillas de C5 en inglés, español y portugués para actividades de análisis y priorización y trabajó con la OPS/OMS y los equipos de país para ejecutar la herramienta C5, analizar los resultados y elaborar productos. En un taller regional de ocho países, se definieron las prioridades en las iniciativas regionales y nacionales, se clasificó su valor y la voluntad política y se incorporaron encuestas específicas para cada país y diálogos con las partes interesadas. Cada país priorizó una actividad estratégica para el período 2022-2023, intercambió ideas por medio de narrativas, y difundió y aplicó los resultados para fundamentar planes de acción tanto regionales como específicos para el país. Los análisis de los talleres nacionales se han incorporado a las actividades de planificación del control del cáncer y al trabajo colaborativo a nivel regional. Entre los factores de éxito de la ejecución se encuentra involucrar a los agentes más allá de lo clínico, permitir que haya flexibilidad y centrarse en un diseño elaborado en colaboración con las partes interesadas. La ejecución conjunta de la herramienta C5 catalizó la priorización y aceleró las actividades estratégicas para mejorar las políticas, la capacidad y la calidad de la atención infantil en la Región de las Américas y brindó apoyo a los ministerios para integrar las intervenciones contra el cáncer infantil en el fortalecimiento de los sistemas.
RESUMO A colaboração com a OPAS/OMS para priorizar o câncer infantil no contexto do fortalecimento dos sistemas é fundamental para o papel do St. Jude Children's Research Hospital (SJCRH) como Centro Colaborador da OMS para o Câncer Infantil. Este artigo mostra como o SJCRH e a OPAS/OMS se associaram para aplicar a ferramenta C5 (Colaboração Nacional para Controle do Câncer Infantil), com o propósito de definir e implementar ações prioritárias regionalmente, fortalecendo programas ministeriais para o câncer na infância, durante a implementação da Iniciativa Global para o Câncer Infantil desde 2018. Com auxílio da C5, uma ferramenta desenvolvida pelo SJCRH, a OPAS/OMS e o SJCRH organizaram conjuntamente oficinas regionais/nacionais com a participação de autoridades, profissionais de saúde e outras partes interessadas em 10 países, com a finalidade de mapear as necessidades dos sistemas de saúde e priorizar atividades estratégicas (abrangendo América Central, República Dominicana, Haiti, Brasil e Uruguai). O SJCRH forneceu versões/modelos da C5 em inglês, espanhol e português para exercícios de análise/priorização e colaborou com a OPAS/OMS e as equipes dos países para implementar a C5, analisar resultados e desenvolver produtos. Em uma oficina regional com oito países, foram definidas as prioridades das iniciativas nacionais/regionais e classificados seu valor e vontade política, incorporando levantamentos nacionais e diálogos entre as partes interessadas. Cada país priorizou uma atividade estratégica para 2022-2023, trocou conhecimentos por meio da narração de histórias e disseminou e aplicou os resultados para informar planos de ação nacionais e regionais. As análises das oficinas nacionais foram incorporadas às atividades de planejamento para controle do câncer e ao trabalho conjunto no âmbito regional. Entre os fatores de êxito da implementação estão o engajamento de agentes de fora do segmento da saúde, a oferta de flexibilidade e a ênfase no planejamento conjunto com as partes interessadas. A implementação conjunta da C5 catalisou a priorização e acelerou atividades estratégicas para aprimorar as políticas, a capacidade e a qualidade da atenção às crianças nas Américas, apoiando os ministérios na integração das intervenções contra o câncer infantil como parte do fortalecimento dos sistemas.
ABSTRACT
Wildfires in the urban-forest interface constitute a civil protection emergency, causing considerable personal injury and damage to properties. The potential impacts of wildfires on buildings can be minimized by reducing the surrounding fuel and the use of structural materials with low flammability. However, the costs associated with implementing these actions and the responsibility for maintenance usually present conflicts with the property owners. This study aimed to identify minimum safety distances in wildland-urban interfaces within priority areas. The priority areas were identified based on the integration of fire risk and fuel hazard. Radiant heat is a variable in the behavior of fire that directly influences the definition of safety distances. In this research the radiant heat transfer was calculated based on the potential fire behavior for each study area. A comparative study of the horizontal heat transfer method and the radiant heat flux model was carried out. The horizontal heat transfer method indicated the highest vegetation-free distances, ranging from 23 m to 32 m. Some safety distances were validated using experimental fires and wildfires. The findings from the experimental fires and wildfires emphasize the need for a progressive fuel load reduction to mitigate radiant heat transfer. This may include both the removal of surface fuel and removal of trees to mitigate against crown fires. Our findings provide relevant information for decision-making on the effectiveness and efficiency of safety distances at the wildland-urban interface.
ABSTRACT
Background: Many countries have developed health initiatives to protect those with disabilities and developmental concerns in the past few years. However, the needs of autistic individuals are still short of being fulfilled. Partially due to limited research expenditure, which would allow bridging the gap between evidence and practice, the long time it takes to implement passed laws, and the limited operationalization of inclusive policies. Objective: To quantitatively examine changes in the child's age at the time of caregiver's first developmental concerns and age of diagnosis of their autistic child across 5 years. Also, to address challenges experienced by caregivers (e.g., reported service barriers) and the work still needing to be done in Argentina based on caregivers' reports of their priorities (e.g., ensuring their child receives better services). Methods: Two independent samples of caregivers of autistic individuals were surveyed by the Red Espectro Autista Latinoamerica (REAL) in 2015 (n = 763) and the World Health Organization (WHO) in 2020 (n = 422). Similar items in both surveys were compared through descriptive inferential analysis and chi-square tests for categorical variables. Results: Compared to the 2015 sample, for the 2020 sample, more caregivers reported an earlier age of first concerns and an earlier age of a professional diagnosis. In the 2020 sample, more children diagnosed before the age of three had a doctor or a teacher noticing the first developmental concern. Also, in this sample, fewer caregivers reported service barriers (e.g., limited availability, waitlist, costs, etc.) and a need for better social support and better health services. However, rates of caregivers indicating a need for more rights for autistic individuals and greater protection of existing rights increased. There was no change in the reported rate of family members who stopped working to care for the autistic individual. For both samples, there was statistically significant differences in individual (physician, teacher, caregiver) noticing first developmental concern and the age of diagnosis, with the majority having a caregiver noticing the first concern. Conclusion: The 5 years that separate both samples show an improvement in developmental concerns being noticed, a decrease in age of diagnosis, and an improvement in several service areas such as community awareness. Also, caregivers reported fewer barriers to service accessibility, thus suggesting a positive impact stemming from changes in public policies, non-profit organizations' work through awareness campaigns, and advocates' strives toward greater awareness. Nonetheless, a similar proportion of family members reported ceasing working to care for autistic individuals and perceived that the fundamental rights of their autistic children needed to be protected. These results imply that despite better care pathways in Argentina, there are still gaps when attempting to meet the needs of autistic individuals and their families. The present study provides a meaningful understanding of existing gaps and help exemplify the perceived improvements when non-profit agencies and advocates promote increased rights and community awareness in addition to the established laws focusing on ASD.
ABSTRACT
Headwaters represent an essential component of hydrological, ecological, and socioeconomical systems, by providing constant water streams to the complete basin. However, despite the high importance of headwaters, there is a lack of vulnerability assessments worldwide. Identifying headwaters and their vulnerability in a spatially explicit manner can enable restauration and conservation programs. In this study, we assess the vulnerability of headwaters in South-Central Chile (38.4 to 43.2°S) considering multiple degradation factors related to climate change and land cover change. We analyzed 2292 headwaters, characterizing multiple factors at five spatial scales by using remote sensing data related to Land Use and Cover Change (LUCC), human disturbances, vegetation cover, climate change, potential water demand, and physiography. We then generated an index of vulnerability by integrating all the analyzed variables, which allowed us to map the spatial distribution of headwater vulnerability. Finally, to estimate the main drivers of degradation, we performed a Principal Components Analysis with an Agglomerative Hierarchical Clustering, that allowed us to group headwaters according to the analyzed factors. The largest proportion of most vulnerable headwaters are located in the north of our study area with 48.1 %, 62.1 %, and 28.1 % of headwaters classified as highly vulnerable at 0, 10, and 30 m scale, respectively. The largest proportion of headwaters are affected by Climate Change (63.66 %) and LUCC (23.02 %) on average across all scales. However, we identified three clusters, in which the northern cluster is mainly affected by LUCC, while the Andean and Coastal clusters are mainly affected by climate change. Our results and methods present an informative picture of the current state of headwater vulnerability, identifying spatial patterns and drivers at multiple scales. We believe that the approach developed in this study could be useful for new studies in other zones of the world and can also promote Chilean headwater conservation.
Subject(s)
Climate Change , Conservation of Natural Resources , Chile , Ecosystem , Humans , Spatial Analysis , WaterABSTRACT
Health systems do not have the capacity to finance all services. The impact of choosing one option or another is important in order to prioritize health resources. Citizen participation can help to set priorities or to select the interventions that will receive public funding. We reviewed the literature searching for articles that reported mechanisms to gather information about citizens' values or preferences about health system coverage. We identified 363 publications, 18 articles were analyzed in full, and 7 articles were included in the review. Three articles were European, two were from Australia and two from Latin America. The most commonly used mechanisms to gather information were interviews and surveys. We conclude that there is a limited number of articles with examples of tools to capture information about values and preferences in health decision processes. The main barrier observed was the lack of standardized processes to collect the values and preferences of the community.
Subject(s)
Humans , Community Participation/methods , Australia , Surveys and Questionnaires , Latin AmericaABSTRACT
ABSTRACT Objectives. To map the timing and nature of regulatory reliance pathways used to authorize COVID-19 vaccines in Latin America. Methods. An observational study was conducted assessing the characteristics of all COVID-19 vaccine authorizations in Latin America. For every authorization it was determined whether reliance was used in the authorization process. Subgroups of reference national regulatory authorities (NRAs) and non-reference NRAs were compared. Results. 56 authorizations of 10 different COVID-19 vaccines were identified in 18 countries, of which 25 (44.6%) used reliance and 12 (21.4%) did not. For the remaining 19 (33.0%) it was not possible to determine whether reliance was used. Reference agencies used reliance less often (40% of authorizations with a known pathway) compared to non-reference agencies (100%). The median review time was just 15 days and does not meaningfully differ between reliance and non-reliance authorizations. Conclusions. This study demonstrated that for these vaccines, despite reliance pathways being associated with numerous rapid authorizations, independent authorization review times were not considerably longer than reliance reviews; reliance pathways were not a prerequisite for rapid authorization. Nevertheless, reliance pathways provided rapid authorizations in response to the COVID-19 emergency.
RESUMEN Objetivos. Determinar dónde y cuándo se usaron las decisiones de autoridades regulatorias de otras jurisdicciones y la naturaleza de estos mecanismos para autorizar vacunas contra la COVID-19 en América Latina. Métodos. Se realizó un estudio observacional para evaluar las características de todas las autorizaciones de vacunas contra la COVID-19 en América Latina. Para cada autorización se determinó si se emplearon las decisiones de autoridades regulatorias de otras jurisdicciones en el proceso de autorización. Se compararon subgrupos de autoridades regulatorias nacionales (ARN) consideradas de referencia con otras ARN no usadas como referencia. Resultados. Se determinó dónde se otorgaron 56 autorizaciones de 10 vacunas diferentes contra la COVID-19 en 18 países; de estas 56 autorizaciones, 25 (44,6%) hicieron uso de las decisiones de autoridades regulatorias de otras jurisdicciones y 12 (21,4%), no. Para las 19 restantes (33,0%) no fue posible determinar si se hizo uso de las decisiones de autoridades regulatorias de otras jurisdicciones. Los organismos de referencia utilizaron las decisiones de autoridades regulatorias de otras jurisdicciones con menos frecuencia (40% de las autorizaciones con un mecanismo conocido) en comparación con los organismos no usados como referencia (100%). El plazo medio de revisión fue de tan solo 15 días y no difiere significativamente entre las autorizaciones que emplearon decisiones de autoridades regulatorias de otras jurisdicciones y las que no las emplearon. Conclusiones. En este estudio se demostró que, a pesar de que los mecanismos de utilización de las decisiones de autoridades regulatorias de otras jurisdicciones se asocian en muchos casos con autorizaciones rápidas, para estas vacunas los plazos de revisión independiente para la autorización no fueron considerablemente mayores que los de las revisiones que emplearon decisiones de autoridades regulatorias de otras jurisdicciones. También se demostró que para obtener una autorización rápida no se requería la utilización de las decisiones de autoridades regulatorias de otras jurisdicciones. Sin embargo, estos mecanismos proporcionaron autorizaciones rápidas en respuesta a la emergencia por la COVID-19.
RESUMO Objetivos. Mapear a tempestividade e a natureza do uso de decisões regulatórias de outras autoridades (reliance regulatório) para autorização de vacinas contra a COVID-19 na América Latina. Métodos. Em um estudo observacional, foram avaliadas as características de todas as autorizações de vacinas contra COVID-19 na América Latina. Para cada autorização, foi determinado se foram utilizadas decisões de outras autoridades regulatórias para embasar o processo de autorização. Foram comparados subgrupos de autoridades reguladoras nacionais (ARN) de referência (ARNr) e ARN não consideradas de referência. Resultados. Foram identificadas 56 autorizações de 10 vacinas diferentes contra a COVID-19 em 18 países, das quais 25 (44,6%) utilizaram decisões de outras ARN como base para o registro e 12 (21,4%) não. Para as 19 (33,0%) autorizações restantes, não foi possível determinar se decisões de outras ARN foram utilizadas. As ARNr utilizaram decisões de outras autoridades com menos frequência (40% das autorizações com via regulatória conhecida) em comparação com as ARN não consideradas de referência (100%). A mediana do tempo de tramitação foi de apenas 15 dias, sem diferença significativa entre processos nos quais foram utilizadas decisões de outras agências e processos que não as utilizaram. Conclusões. Este estudo demonstrou que, para estas vacinas, apesar de o uso do reliance regulatório estar associado a várias autorizações rápidas, os tempos de tramitação não foram consideravelmente maiores em autorizações independentes do que quando foram utilizadas decisões de outras ARN; o reliance regulatório não foi um pré-requisito para autorização rápida. No entanto, o uso de tais processos viabilizou autorizações rápidas em resposta à emergência de COVID-19.
ABSTRACT
ABSTRACT OBJECTIVE Defining priority vaccination groups is a critical factor to reduce mortality rates. METHODS We sought to identify priority population groups for covid-19 vaccination, based on in-hospital risk of death, by using Extreme Gradient Boosting Machine Learning (ML) algorithm. We performed a retrospective cohort study comprising 49,197 patients (18 years or older), with RT-PCR-confirmed for covid-19, who were hospitalized in any of the 336 Brazilian hospitals considered in this study, from March 19th, 2020, to March 22nd, 2021. Independent variables encompassed age, sex, and chronic health conditions grouped into 179 large categories. Primary outcome was hospital discharge or in-hospital death. Priority population groups for vaccination were formed based on the different levels of in-hospital risk of death due to covid-19, from the ML model developed by taking into consideration the independent variables. All analysis were carried out in Python programming language (version 3.7) and R programming language (version 4.05). RESULTS Patients' mean age was of 60.5 ± 16.8 years (mean ± SD), mean in-hospital mortality rate was 17.9%, and the mean number of comorbidities per patient was 1.97 ± 1.85 (mean ± SD). The predictive model of in-hospital death presented area under the Receiver Operating Characteristic Curve (AUC - ROC) equal to 0.80. The investigated population was grouped into eleven (11) different risk categories, based on the variables chosen by the ML model developed in this study. CONCLUSIONS The use of ML for defining population priorities groups for vaccination, based on risk of in-hospital death, can be easily applied by health system managers
Subject(s)
Humans , Adult , Middle Aged , Aged , COVID-19 Vaccines , COVID-19/prevention & control , Brazil/epidemiology , Retrospective Studies , Vaccination , Hospital Mortality , Machine LearningABSTRACT
RESUMEN Introducción: Las líneas de investigación aprobadas en las universidades peruanas deberían considerar dentro de sus ejes temáticos problemas sanitarios del país, sobre todo en el campo de la salud mental, en el cual hay un déficit de producción científica. Objetivo: Determinar la frecuencia de líneas de investigación que incluyen salud mental como prioridad de estudio en universidades peruanas. Métodos: Estudio observacional descriptivo. Las unidades de análisis fueron las líneas de investigación aprobadas y disponibles en el sitio web de 34 universidades peruanas que ofertan la carrera de psicología y que obtuvieron el licenciamiento institucional hasta el año 2019. Resultados: El 48 % de líneas de investigación considera como prioridad de estudio a los factores asociados a la depresión, violencia, conductas adictivas, psicosis y demencias; un 20 % al estado de la salud mental negativa y positiva; 4 % al desarrollo de estrategias intersectoriales con adecuación cultural, y otro 4 % a la evaluación de estrategias de prevención y promoción en salud mental con participación intersectorial. En cambio, ninguna considera la dinámica de los determinantes sociales, biológicos, comportamentales, familiares y ambientales, ni la implementación de la oferta de servicios para la atención de la salud mental según etapas de vida. Conclusiones: La frecuencia de líneas de investigación que incluyen salud mental como prioridad de estudio en universidades peruanas es baja. Esto puede repercutir en la producción científica en salud mental y la calidad de la investigación formativa en el pregrado.
ABSTRACT Introduction: The lines of research approved in Peruvian universities should consider within their thematic axis health problems of the country, especially in the field of mental health, where there is a deficit of scientific production. Objective: To determine the frequency of research lines that include mental health as a study priority in Peruvian universities. Methods: Descriptive observational study. The units of analysis were the lines of research approved and available on the website of 34 Peruvian universities that offer psychology courses and that obtained institutional licensing until 2019. Results: 48% of the lines of research consider as a priority of study the factors associated with depression, violence, addictive behaviors, psychosis and dementia; 20% the state of negative and positive mental health; 4% the development of intersectoral strategies with cultural appropriateness, and another 4% the evaluation of prevention and promotion strategies in mental health with intersectoral participation. In contrast, none consider the dynamics of social, biological, behavioral, family and environmental determinants, nor the implementation of the supply of services for mental health care according to life stages. Conclusions: The frequency of research lines that include mental health as a priority of study in Peruvian universities is low. This may have repercussions on the scientific production in mental health and the quality of formative research at the undergraduate level.
ABSTRACT
Resumen Para tomar decisiones en conservación o manejo de especies silvestres es prioritario conocer su estado de conservación, siendo el método de la IUCN el más utilizado para categorizar especies según su nivel de amenaza, tanto a nivel global como a nivel nacional. En este artículo realizamos un análisis de las especies de plantas y vertebrados amenazadas y de aquellas con datos insuficientes del departamento de Loreto, el más grande y uno de los más biodiversos del Perú, con el fin de identificar las principales amenazas que soportan, identificar los vacíos de información y comparar la congruencia entre la lista nacional y la global. Uniendo ambas listas, en Loreto se ha registrado 226 especies consideradas amenazadas. Existen grandes diferencias entre la lista nacional y la global, principalmente para plantas y peces. La principal amenaza registrada es la pérdida de hábitat, que afecta a la mayor parte de las especies de vertebrados terrestres amenazados. Existen grandes vacíos de información sobre tamaño y tendencia poblacional en todos los grupos taxonómicos, y de distribución en las plantas amenazadas. Entre las especies con datos insuficientes, los vacíos principales se dan en los aspectos de distribución y población, pero también en amenazas, ecología y taxonomía. Nuestros resultados resaltan la necesidad de actualizar la lista de plantas amenazadas del Perú, así como crear una lista de peces amenazados y realizar investigación sobre distribución, población, amenazas y taxonomía de las especies con datos insuficientes y de las especies amenazadas con vacíos de información.
Abstract In order to make decisions on the conservation or management of wild species, it is a priority to know their conservation status. For this purpose, the most widely used method is IUCN's categorization of species according to the level of threat they face, both globally and nationally. In this article we conducted an analysis of threatened plant and vertebrate species, and of data deficient species in the department of Loreto, the largest and one of the most biodiverse in Peru, to identify the main threats they face, identify information gaps, and compare the national and global lists. According to both lists combined, 226 species considered threatened have been recorded in Loreto. Large differences exist between the national and global lists, mainly for plants and fish. The main threat recorded is habitat loss, which affects most of the threatened terrestrial vertebrate species. Large gaps persist in information on population size and trends for all taxonomic groups, and on distribution for threatened plants. Among the data deficient species, the main gaps are in distribution and population aspects, but also in threats, ecology, and taxonomy. Our results highlight the need to update the list of threatened plants of Peru, as well as to create a list of threatened fish species and to conduct research on the distribution, population, threats, and taxonomy of species with deficient data and threatened species with information gaps.
ABSTRACT
Procuramos identificar os critérios que conduzem à seleção para investigação de determinadas patologias. O objetivo é verificar se tais critérios são adequados às necessidades de investigação em saúde e respondem aos problemas globais de saúde pública. Tentámos confrontar o que diz a informação científica publicada com a nossa experiência na Comissão de Ética para a Investigação Clínica. Na maioria dos repositórios consultados, há poucas referências a prioridades ou seleção de prioridades, reportando-se a aspetos concretos de patologias específicas. O motor de busca EuropePMC identifica perto de 40 milentradas, sendo o mais significativo que encontrámos. Analisámos alguns dos artigos pela abordagem ética, metodológica para a investigação médica e suas prioridades, nomeadamente, a participação dos pacientes. A interação entre medicamentos antirretrovirais e o consumo de drogas injetáveis e a inclusão de pacientes utilizadores de injetáveis (UDI) em ensaios clínicos só foram investigadas pelas companhias farmacêuticas (e pelos próprios investigadores), pelo confronto e pressão dos principais Community Advisory Boards (CAB), nomeadamente o European CAB. A seleção e arbitragem entre patologias para a investigação não parecem despertar muito interesse por parte de investigadores e da Academia. São os financiadores da investigação, entidades, públicas ou privadas, com ou sem fins lucrativos, que selecionam as áreas a investigar. Nas empresas farmacêuticas, é o retorno económico: doenças de países e regiões de baixos recursos ou raras não têm um mercado. Têm sido as organizações multilaterais e fundações de âmbito global, com os seus financiamentos, a definir as prioridades das investigações em áreas de maior impacto global e social.
We try to identify the criteria leadingto the selection for investigation of certain pathologies. Its goal is to verify whether these criteria are adequate to the global health research needs and respond to the main global public health problems.We tried to confrontwhat the published scientific information says with our own experience as a member of the Ethics Committee for Clinical Research.Most of the open access repositories consulted, refers, mostly, to specificpathologies, with few references to priorities or selection of priorities.The EuropePMC search engine, the most significant of which wehave found,identifies nearly 40.000 entries. We analyzed some of the articles by the ethical, methodological approach to medical research and its priorities, namely, patient participation.Interactionsbetween antiretroviral drugs and injecting drug use and the inclusion of drug user patients in clinical trials where only be investigated by pharmaceutical companies (and the researchers themselves), with the confrontation and pressure from the main Community Advisory Boards(CAB), in particular European CAB.The selection and arbitration between pathologies for research does not seem, comparatively, to raiseinterest on the part of researchers and the Academy. The research funders define the financeable areas.In pharmaceutical companies, it is the economic return, with little interest and social impact of the research results. Diseases in low-resource or rare countries and regions are not an interestingmarket.Multilateral organizations and global foundations have been responsible for prioritizing funding for research in areas of greatest global and social impact.
Buscamos identificar los criterios conducentesa la selecciónpara la investigación de determinadas patologías. Su objetivo último es verificar si dichos criterios son adecuados a las necesidades de investigación en salud y a los problemas de salud pública global.Intentamos confrontarlo que dice la información científica publicada con nuestra experiencia en el Comité de Ética para la Investigación Clínica.La mayoría de los repositorios de acceso abierto consultadosse refieren a patologías concretas,contienen pocas referencias a prioridades o selección de prioridades.El motor de búsqueda EuropePMC,lo más significativoque hemosencontrado,identifica cerca de 40.000 entradas. Analizamos algunos de los artículos por el enfoque ético, metodológico de la investigación médica y sus prioridades, a saber, la participación de los pacientes. Lasinteraccionesentre los medicamentos antirretrovirales y el uso de drogas inyectables y la inclusión de pacientes UDI enensayos clínicos solo fueron investigadas por loenfrentamiento ypresión de los principales Community Advisory Boards(CAB), en particular European CAB.La selección y arbitraje entre patologías para la investigación no parecedespertar mucho interés por parte de los investigadores y de la Academia. Los financiadores de investigación definen las áreas financiables.En las empresas farmacéuticas es el retorno económico, con poco interés e impacto social de los resultados de la investigación. Los países y regiones de recursos escasos o raros no tienen interés económico, no tienen mercado.Las organizacionesy fundaciones multilaterales a nivel global se han encargado de priorizar la financiación de la investigación en áreas de mayor impacto global y social.